Skip to main content
. 2025 Oct 13;8:609. doi: 10.1038/s41746-025-01970-y

Table 1.

Clinical and pathological characteristics of all datasets

Characteristics Training set Validation set Test 1 Test 2 Test 3
(n = 999) (n = 250) (n = 173) (n = 289) (n = 124)
Age (years), Median (IQR) 56.0(23.0) 55.0(23.3) 57.0(25.0) 56.0(20.5) 63.0(12.0)
Sex, n(%)
Female 560(56) 147(58.8) 96(55.4) 172(59.5) 53(42.7)
Male 439(44) 103(41.2) 77(44.6) 117(40.5) 71(57.3)
BMI (kg/m2), Mean ± SD 23.0 ± 3.3 22.7 ± 3.2 22.7 ± 3.5 23.2 ± 3.7 22.4 ± 3.2
CA19-9 μmol/L, Median (IQR) 9.1(18.4) 9.3(17.0) 7.9(20.5) 10.8(15.4) 13.4(19.6)
CEA (ng/ml), Median (IQR) 2.0(2.0) 1.9(1.8) 1.7(2.2) 0.8(1.4) 2.2(2.1)
Abdominal pain, n(%) 350(35.0) 99(39.6) 58(33.5) 84(29.0) 27(21.7)
Jaundice, n(%) 41(4.1) 9(3.6) 7(4.0) 5(1.7) 4(3.2)
Diabetes, n(%) 145(14.5) 19(7.6) 26(15) 30(10.3) 8(6.4)
Alcohol consumption, n(%) 80(8.0) 22(8.8) 15(8.6) 33(11.4) 7(5.6)
Family history, n(%) 18(1.8) 3(1.2) 1(0.5) 12(4.1) 0(0.0)
Pathological classification, n(%)
Precancerous IPMN 299(29.9) 90(36.0) 50(28.9) 74(25.6) 57(46.0)
Malignant IPMN 214(21.4) 39(15.6) 40(23.1) 30(10.4) 37(29.8)
Precancerous MCN 72(7.2) 18(7.2) 13(7.5) 47(16.3) 6(4.8)
Malignant MCN 7(0.7) 1(0.4) 1(0.6) 1(0.3) 1(0.8)
SCN 212 (21.2) 53(21.2) 37(21.3) 84(29.0) 10(8.0)
SPN 195 (19.5) 49(19.6) 32(18.4) 53(18.3) 13(10.4)

Note: Categorical variables are expressed as the number of cases (%), and continuous variables as the median (interquartile range).

IPMN intraductal papillary mucinous cystic neoplasms, MCN mucinous cystic neoplasms, SCN serous cystic neoplasms, SPN solid pseudopapillary neoplasms.